HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Prostate cancer is a prevalent form of cancer that affects the prostate, a small walnut-shaped gland in men that produces seminal fluid. It is the second most common cancer among men worldwide. While prostate cancer often progresses slowly and may not cause noticeable symptoms in its early stages, it can become more aggressive over time. Therefore, early detection and appropriate management are crucial for optimal outcomes. Risk factors for prostate cancer include age, with the risk increasing significantly after the age of 50, and family history. African-American men have a higher incidence of prostate cancer compared to other racial and ethnic groups.
Additionally, a diet high in red meat and low in fruits and vegetables may contribute to an increased risk. Screening for prostate cancer typically involves a prostate-specific antigen (PSA) blood test and a digital rectal examination (DRE). Elevated PSA levels can indicate potential issues with the prostate, although an elevated PSA doesn't necessarily indicate cancer. Further diagnostic tests, such as a prostate biopsy, are often conducted to confirm the presence of cancer and determine its aggressiveness. Treatment options for prostate cancer depend on factors such as the stage of the cancer, the patient's overall health, and the aggressiveness of the tumor. Treatment modalities may include active surveillance, surgery (prostatectomy), radiation therapy, hormone therapy, chemotherapy, or immunotherapy. The choice of treatment is often individualized, considering the specific characteristics of the cancer and the patient's preferences.
